Applied Molecular Transport Announces Publication in Tissue Barriers Providing Additional Insight into Company’s Proprietary Technology Platform
April 13, 2022 08:00 ET
|
Applied Molecular Transport Inc.
Publication describes critical interactions between cholix-based transport domain and endogenous intracellular trafficking pathways used by Company’s proprietary biologic product candidates to cross...
Applied Molecular Transport Appoints Charlene Banard to its Board of Directors
April 06, 2022 08:00 ET
|
Applied Molecular Transport Inc.
SOUTH SAN FRANCISCO, Calif., April 06, 2022 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced the appointment of...
Applied Molecular Transport Appoints Industry Veteran Carolyn Finkle as Senior Vice President, Head of Regulatory Affairs
March 14, 2022 08:00 ET
|
Applied Molecular Transport Inc.
Company continues to strengthen key functions and corporate leadership Company on track to announce top-line data from four ongoing oral AMT-101 Phase 2 trials in 2022 SOUTH SAN FRANCISCO, Calif.,...
Applied Molecular Transport Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
February 24, 2022 16:01 ET
|
Applied Molecular Transport Inc.
Four top-line data readouts expected in 2022 from ongoing oral AMT-101 Phase 2 trials, as follows FILLMORE monotherapy trial for patients with chronic pouchitis followed by MARKET combination trial...
Applied Molecular Transport to Present at SVB Leerink Virtual 11th Annual Global Healthcare Conference
February 10, 2022 08:00 ET
|
Applied Molecular Transport Inc.
SOUTH SAN FRANCISCO, Calif., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Tahir Mahmood,...
Applied Molecular Transport Announces Board Appointments
January 27, 2022 16:30 ET
|
Applied Molecular Transport Inc.
John W. Smither Appointed to its Board of Directors and Named Audit Committee Chair Graham K. Cooper Named Executive Chair Helen S. Kim Named Lead Independent Director SOUTH SAN FRANCISCO, Calif.,...
Applied Molecular Transport to Present at Virtual Jefferies London Healthcare Conference
November 15, 2021 08:00 ET
|
Applied Molecular Transport Inc.
SOUTH SAN FRANCISCO, Calif., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Bittoo Kanwar,...
Applied Molecular Transport Reports Third Quarter 2021 Financial Results and Provides Corporate Update
November 10, 2021 16:01 ET
|
Applied Molecular Transport Inc.
Top-line data readout for oral AMT-101 Phase 2 MARKET combination trial with anti-TNFα in ulcerative colitis (UC) expected in H1 2022 Top-line data readouts from three additional oral AMT-101 Phase 2...
Applied Molecular Transport to Host Virtual Research & Development Day on October 15, 2021
October 11, 2021 16:01 ET
|
Applied Molecular Transport Inc.
Management to highlight novel oral biologics technology platform, clinical programs and research activities Feature distinguished IBD and rheumatology key opinion leaders Provide update on the four...
Applied Molecular Transport Announces Upcoming Investor Events in September and October
September 17, 2021 08:00 ET
|
Applied Molecular Transport Inc.
SOUTH SAN FRANCISCO, Calif., Sept. 17, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that the company...